Join
Live feed
·
SECFilingvia Quantisnow
CTI BioPharma Corp. (DE) logo

CTI BioPharma Corp. filed SEC Form 8-K: Entry Into A Material Definitive Agreement On March 31, 2021, Cti Biopharma Corp, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
CTIC· CTI BioPharma Corp. (DE)
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTIC (CTI BioPharma Corp. (DE)) and more on Quantisnow.

CTI BioPharma Corp. filed SEC Form 8-K: Entry Into A Material Definitive Agreement On March 31, 2021, Cti Biopharma Corp, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits | Quantisnow